To search the FD&C Act on the Law Revision Counsel website, you may either search by U.S. code section number or browse the Title 21 section listing.
FD&C Act Section Number | Title |
---|---|
Sec. 501 | Sec. 351 - Adulterated drugs and devices |
Sec. 502 | Sec. 352 - Misbranded drugs and devices |
Sec. 503 | Sec. 353 - Exemptions and consideration for certain drugs, devices, and biological products |
Sec. 503A | Sec. 353a - Pharmacy compounding |
Sec. 503A-1 | Sec. 353a-1 - Enhanced Communication |
Sec. 503B | Sec. 353b - Outsourcing facilities |
Sec. 503C | Sec. 353c - Prereview of television advertisements |
Sec. 504 | Sec. 354 - Veterinary feed directive drugs |
Sec. 505 | Sec. 355 - New drugs |
Sec. 355-1 - Risk evaluation and mitigation strategies | |
Sec. 505A | Sec. 355a - Pediatric studies of drugs |
Sec. 355b - Adverse-event reporting | |
Sec. 505B | Sec. 355c - Research into pediatric uses for drugs and biological products |
Sec. 355c-1 - Report | |
Sec. 505C | Sec. 355d - Internal committee for review of pediatric plans, assessments, deferrals, and waivers |
Sec. 505D | Sec. 355e - Pharmaceutical security |
Sec. 506 | Sec. 356 - Fast track products |
Sec. 355f - Extension of exclusivity period for new qualified infectious disease products | |
Sec. 356. Expedited approval of drugs for serious or life-threatening diseases or conditions | |
Sec. 356-1 - Accelerated approval of priority countermeasures | |
Sec. 506A | Sec. 356a - Manufacturing changes |
Sec. 506B | Sec. 356b - Reports of postmarketing studies |
Sec. 506C | Sec. 356c - Discontinuance or interruption in the production of life-saving drugs |
Sec. 356c-1 - Annual reporting on drug shortages | |
Sec. 356d - Coordination; task force and strategic plan | |
Sec. 356e - Drug shortage list | |
Sec. 356f - Hospital repackaging of drugs in shortage | |
Sec. 357 - Repealed. Pub. L. 105-115, title I, §125(b)(1), Nov. 21, 1997, 111 Stat. 2325 | |
Sec. 508 | Sec. 358 - Authority to designate official names |
Sec. 509 | Sec. 359 - Nonapplicability of subchapter to cosmetics |
Sec. 510 | Sec. 360 - Registration of producers of drugs or devices |
Sec. 511 | Sec. 360a - Clinical trial guidance for antibiotic drugs |
Sec. 360a-1 - Clinical trials | |
Sec. 512 | Sec. 360b - New animal drugs |
Sec. 513 | Sec. 360c - Classification of devices intended for human use |
Sec. 360c-1 - Reporting | |
Sec. 514 | Sec. 360d - Performance standards |
Sec. 515 | Sec. 360e - Premarket approval |
Sec. 515A | Sec. 360e-1 - Pediatric uses of devices |
Sec. 516 | Sec. 360f - Banned devices |
Sec. 517 | Sec. 360g - Judicial review |
Sec. 360g-1. Agency documentation and review of significant decisions regarding devices | |
Sec. 518 | Sec. 360h - Notification and other remedies |
Sec. 360h-1. Program to improve the device recall system | |
Sec. 519 | Sec. 360i - Records and reports on devices |
Sec. 520 | Sec. 360j - General provisions respecting control of devices intended for human use |
Sec. 521 | Sec. 360k - State and local requirements respecting devices |
Sec. 522 | Sec. 360l - Postmarket surveillance |
Sec. 523 | Sec. 360m - Accredited persons |
Sec. 524 | Sec. 360n - Priority review to encourage treatments for tropical diseases |
Sec. 360n-1. Priority review for qualified infectious disease products |
FD&C Act Section Number | Title |
---|---|
Sec. 525 | Sec. 360aa - Recommendations for investigations of drugs for rare diseases or conditions |
Sec. 526 | Sec. 360bb - Designation of drugs for rare diseases or conditions |
Sec. 527 | Sec. 360cc - Protection for drugs for rare diseases or conditions |
Sec. 528 | Sec. 360dd - Open protocols for investigations of drugs for rare diseases or conditions |
Sec. 360ee - Grants and contracts for development of drugs for rare diseases and conditions | |
Sec. 360ff - Priority review to encourage treatments for rare pediatric diseases |
FD&C Act Section Number | Title |
---|---|
Sec. 531 | Sec. 360hh - Definitions |
Sec. 532 | Sec. 360ii - Program of control |
Sec. 533 | Sec. 360jj - Studies by Secretary |
Sec. 534 | Sec. 360kk - Performance standards for electronic products |
Sec. 535 | Sec. 360ll - Notification of defects in and repair or replacement of electronic products |
Sec. 536 | Sec. 360mm - Imports |
Sec. 537 | Sec. 360nn - Inspection, records, and reports |
Sec. 538 | Sec. 360oo - Prohibited acts |
Sec. 539 | Sec. 360pp - Enforcement |
Sec. 360qq - Repealed. Pub. L. 105-362, title VI, §601(a)(2)(A), Nov. 10, 1998, 112 Stat. 3285 | |
Sec. 541 | Sec. 360rr - Federal-State cooperation |
Sec. 542 | Sec. 360ss - State standards |
FD&C Act Section Number | Title |
---|---|
Secs. 360aaa to 360aaa-6 - Omitted |
FD&C Act Section Number | Title |
---|---|
Sec. 561 | Sec. 360bbb - Expanded access to unapproved therapies and diagnostics |
Sec. 652 | Sec. 360bbb-1 - Dispute resolution |
Sec. 563 | Sec. 360bbb-2 - Classification of products |
Sec. 564 | Sec. 360bbb-3 - Authorization for medical products for use in emergencies |
Sec. 360bbb-3a - Emergency use of medical products | |
Sec. 360bbb-3b - Products held for emergency use | |
Sec. 565 | Sec. 360bbb-4 - Countermeasure development, review, and technical assistance |
Sec. 566 | Sec. 360bbb-5 - Critical Path Public-Private Partnerships |
Sec. 567 | Sec. 360bbb-6 - Risk communication |
Sec. 360bbb-7 - Notification | |
Sec. 360bbb-8 - Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments | |
Sec. 360bbb-8a - Optimizing global clinical trials | |
Sec. 360bbb-8b - Use of clinical investigation data from outside the United States | |
Sec. 360bbb-8c - Patient participation in medical product discussion |
FD&C Act Section Number | Title |
---|---|
Sec. 571 | Sec. 360ccc - Conditional approval of new animal drugs for minor use and minor species |
Sec. 572 | Sec. 360ccc-1 - Index of legally marketed unapproved new animal drugs for minor species |
Sec. 573 | Sec. 360ccc-2 - Designated new animal drugs for minor use or minor species |
FD&C Act Section Number | Title |
---|---|
Sec. 360ddd - Definitions | |
Sec. 360ddd-1 - Regulation of medical gases | |
Sec. 360ddd-2 - Inapplicability of drug fees to designated medical gases |
FD&C Act Section Number | Title |
---|---|
Sec. 360eee - Definitions | |
Sec. 360eee-1 - Requirements | |
Sec. 360eee-2 - National standards for prescription drug wholesale distributors | |
Sec. 360eee-3 - National standards for third-party logistics providers | |
Sec. 360eee-4 - Uniform national policy |
FD&C Act Section Number | Title |
---|---|
Sec. 360fff - Definitions | |
Sec. 360fff-1 - Submission of requests | |
Sec. 360fff-2 - Eligibility determinations; data submission; filing | |
Sec. 360fff-3 - GRASE determination | |
Sec. 360fff-4 - Guidance; other provisions | |
Sec. 360fff-5 - Sunscreen monograph | |
Sec. 360fff-6 - Non-sunscreen time and extent applications | |
Sec. 360fff-7 - Report |